NXPL News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$25.1M

Volume

15.36K

Next Earnings

November 11th

Mkt Cap

$26.3M

Volume

15.36K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

NextPlat Announces 1-for-10 Reverse Stock Split to Be Effective Prior to Market Open on April 13, 2026NextPlat Corp announced a 1-for-10 reverse stock split effective April 13, 2026, consolidating approximately 26.9 million shares into 2.7 million shares. The company's common stock will continue trading under ticker symbol NXPL with a new CUSIP number. Shareholders with fractional shares will receive cash payments in lieu.Benzinga · Apr 2, 2026

NextPlat Launches 50 State Nationwide Medication Fulfillment Capabilities, Supporting Healthcare Revenue Growth in 2026 and BeyondNextPlat Corp announced a partnership with HealthWarehouse.com to enable nationwide prescription and over-the-counter medication fulfillment across all 50 U.S. states. The collaboration significantly expands NextPlat's healthcare footprint beyond Florida, where it currently generates over 70% of its $55 million annual revenue, and aims to accelerate geographic expansion and e-commerce growth in 2026.Benzinga · Mar 26, 2026

NextPlat Expects Approximately $55 Million in 2025 Revenue and Reports Strong Sequential Momentum with Cost Reductions and Margin Expansion Expected into 2026NextPlat Corp reported strong sequential momentum in Q4 2025 with expected $55 million in annual revenue. The company expects significant gross margin expansion of 20-25% in Q1 2026, driven by growth in higher-margin 340B healthcare services and contracted fulfillment. Cost reduction initiatives and operational efficiencies are underway, with management expecting meaningful reductions in operating losses by mid-2026.Benzinga · Feb 25, 2026

NextPlat Issues CEO Shareholder Update LetterNextPlat Corp provides an update on its strategic progress across healthcare services, communications, and e-commerce channels, highlighting cost reduction efforts, new contracts, and technology investments aimed at driving growth and profitability.Benzinga · Oct 8, 2025

NextPlat Issues Interim CEO Update Shareholder LetterNextPlat's interim CEO David Phipps outlined strategic plans to improve healthcare and e-commerce divisions, focusing on operational efficiency, cost reduction, and exploring growth opportunities following the unexpected passing of former CEO Charles M. Fernandez.Benzinga · Jun 30, 2025

US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights 'Fairly Weak Returns' After 5%+ Gains In S&P 500U.S. stock futures are expected to open lower ahead of the March inflation data release. Experts highlight that after the S&P 500's 5%+ gains on Wednesday, the returns in the near term are likely to be 'fairly weak'.Benzinga · Apr 10, 2025

NextPlat Announces Completion of Merger and Business Combination with Progressive Care Inc. as Company Focuses on Growth in Healthcare, Technology and Personal Wellness MarketsNextPlat Corp has completed the merger and business combination with Progressive Care Inc., creating a unified company focused on growth in healthcare, technology, and personal wellness markets. The combined entity expects to generate continued improvements in financial performance through business integration and new product launches.Benzinga · Oct 1, 2024

NextPlat Announces Results of Annual Meeting of StockholdersNextPlat Corp announced the results of its annual stockholder meeting, including the approval of the business combination with Progressive Care Inc. The combined company is expected to close on October 1, 2024.Benzinga · Sep 16, 2024

Progressive Care Inc. Announces Results of Special Meeting of StockholdersProgressive Care Inc. announced that its shareholders approved the business combination with NextPlat Corp, with the closing expected on October 1, 2024. Under the terms, Progressive Care shareholders will receive 1.4865 shares of NextPlat for each share they own.Benzinga · Sep 16, 2024

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day SessionShares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms. Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Soligenix, Inc. (NASDAQ: SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA. Longeveron Inc. (NASDAQ: LGVN) surged 54% to $2.6350 following insider buys from multiple company executives. SuperCom Ltd. (NASDAQ: SPCB) shares gained 39.4% to $0.3849 after jumping around 18% on Friday. Piedmont Lithium Inc. (NYSE: PLL) shares gained 32.1% to $16.75 following a 5% decline on Friday. Snap One Holdings Corp. (NASDAQ: SNPO) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies. Organovo Holdings, Inc. (NASDAQ: ONVO) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo. Kuke Music Holding Limited (NASDAQ: KUKE) jumped 27% to $2.7650. HUB Cyber Security Ltd. (NASDAQ: HUBC) gained 24% to $1.61 after gaining over 11% on Friday. Edgio, Inc. (NASDAQ: EGIO) gained 24% to $22.18. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ...Benzinga · Apr 15, 2024

NXPLNextPlat Corp Common Stock

NXPL

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any NXPL yet.

Related Tickers

Earnings

Mkt Cap

$25.1M

Volume

15.36K

Next Earnings

November 11th